SCM
SNY icon

Superstring Capital Management’s Sanofi SNY Stock Holding History

Superstring Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50,407
Closed -$2.38M – 60
2025
Q3 		$2.38M Buy
+50,407
New +$2.43M 2.34% 19

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Superstring Capital Management's SNY Position: Q4 2025 in Review

Superstring Capital Management sold out of Sanofi (SNY) in Q4 2025, closing a stake of 50,407 shares — an estimated $2.38M sold.

Superstring Capital Management first reported a position in SNY in Q3 2025 and held it in 1 quarter. The position peaked at $2.38M in Q3 2025. 754 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Superstring Capital Management reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Superstring Capital Management sold 50,407 Sanofi shares in Q4 2025, an estimated $2.38M.
  • Superstring Capital Management first reported a position in Sanofi in Q3 2025 and held it in 1 quarter.
  • Superstring Capital Management's Sanofi position peaked at $2.38M in Q3 2025.
  • 754 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Superstring Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.